Drug Discovery ÀÎÆ÷¸Åƽ½º ½ÃÀå º¸°í¼­ : ¿öÅ©Ç÷ο캰, ±â´Éº°, ¸ðµåº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Others), and Region 2025-2033
»óǰÄÚµå : 1819913
¸®¼­Ä¡»ç : IMARC
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 137 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,249,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,666,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,084,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Drug Discovery ÀÎÆ÷¸Åƽ½º ½ÃÀå ±Ô¸ð´Â 2024³â 36¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 84¾ï ´Þ·¯¿¡ ´ÞÇØ 2025³âºÎÅÍ 2033³â±îÁö 9.21%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

Drug Discovery ÀÎÆ÷¸Åƽ½º´Â ´ë·®ÀÇ »ýÈ­ÇÐ µ¥ÀÌÅ͸¦ ºÐ¼®Çϰí ÇØ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼ú ¼Ö·ç¼ÇÀÔ´Ï´Ù. µ¥ÀÌÅÍ´Â ¿¬±¸ ¸ñÀûÀ¸·Î ÀÓ»ó ½ÇÇè½Ç¿¡¼­ ¼öÇàµÈ ½ÇÇè¿¡¼­ »ý¼ºµÇ¸ç, ´Ù¾çÇÑ ¾à¹° °³¹ß¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ È°¿ëµË´Ï´Ù. ½ÃÄö½Ì, Ÿ°Ù µ¥ÀÌÅÍ ºÐ¼®, µ¥ÀÌÅÍ ½Ã°¢È­, µµÅ·, ºÐÀÚ ¸ðµ¨¸µ, ½Å¾à °³¹ßÀ» À§ÇÑ µ¥ÀÌÅͺ£À̽º º¸È£ µî ´Ù¾çÇÑ ¼ÒÇÁÆ®¿þ¾î ¹× Çϵå¿þ¾î ±â¹Ý µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. ±× °á°ú, ÀÇ·á±â°ü, Á¦¾à-¹ÙÀÌ¿ÀÅØ ±â°ü, CRO(ÀǾàǰ °³¹ß ¾÷¹« À§Å¹±â°ü) µî¿¡¼­ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

Àü ¼¼°è ÇコÄÉ¾î ¹× Á¦¾à »ê¾÷ÀÇ °ý¸ñÇÒ¸¸ÇÑ ¼ºÀåÀº ½ÃÀå Àü¸ÁÀ» ¹à°Ô ¸¸µå´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Èñ±Í Áúȯ Ä¡·á¿¡ ´ëÇÑ È¿°úÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Drug Discovery ÀÎÆ÷¸Åƽ½º´Â Á¦¾àȸ»ç°¡ ½Å¾àÀÇ ½Çü¸¦ ºÐ¼®Çϰųª ¿©·¯ ÃâóÀÇ »ý¹°ÇÐÀû Á¤º¸¸¦ ´Ù·ê ¶§ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ðµ¨¸µ°ú ½Ã¹Ä·¹À̼ÇÀ» ÅëÇØ ¾àµ¿ÇÐÀû °á°ú ¿¹ÃøÀ» Áö¿øÇÏ´Â Çõ½ÅÀûÀÎ »ý¸®Àû ¾àµ¿ÇÐ(PBPK) ½Ã¹Ä·¹ÀÌÅÍ Ç÷§Æû °³¹ß µî ´Ù¾çÇÑ ±â¼ú ¹ßÀüµµ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿ÀÆÝµå·° °³¹ßÀ» À§ÇÑ Á¤ºÎ ¹× ¹Î°£ ÀÇ·á±â°üÀÇ ÅõÀÚ Áõ°¡µµ ½ÃÀå °³Ã´¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ °í·É Àα¸ÀÇ Áõ°¡, ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ºÐ¾ßÀÇ ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿ µîÀÌ ½ÃÀåÀ» ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ Drug Discovery ÀÎÆ÷¸Åƽ½º ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : ¿öÅ©Ç÷ο캰

Á¦7Àå ½ÃÀå ³»¿ª : ±â´Éº°

Á¦8Àå ½ÃÀå ³»¿ª : ¸ðµåº°

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global drug discovery informatics market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Workflow:

Breakup by Function:

Breakup by Mode:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Drug Discovery Informatics Market

6 Market Breakup by Workflow

7 Market Breakup by Function

8 Market Breakup by Mode

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â